-

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Globe Life Inc.’s Directors and Officers for Breach of Fiduciary Duties – GL

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Globe Life Inc. (“Globe Life”) (NYSE: GL) breached their fiduciary duties to Globe Life and its shareholders. If you are a Globe Life shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether members of Globe Life’s board of directors or senior management failed to manage Globe Life in an acceptable manner, in breach of their fiduciary duties, and whether Globe Life and its shareholders have suffered damages as a result.

On February 24, 2023, Insider published an article describing pervasive misogyny and toxic workplace conditions at Arias Agency, a top state general agent of American Income Life Insurance Company (“AIL”), Globe Life’s largest insurance subsidiary.

What You Can Do

If you are a Globe Life shareholder, you may have legal claims against Globe Life’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:GL

Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)

NEW YORK--(BUSINESS WIRE)--The lead plaintiff deadline throughout the release dated February 6, 2026, should read April 13, 2026 (instead of April 6, 2026). The updated release reads: SCOTT+SCOTT ATTORNEYS AT LAW LLP FILES SECURITIES CLASS ACTION AGAINST POMDOCTOR, LTD. (NASDAQ: POM) Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor Ltd., Zhenyan...

CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Picard Medical Inc. (NASDAQ: PMI)

NEW YORK--(BUSINESS WIRE)--The lead plaintiff deadline throughout the release dated February 3, 2026, should read April 13, 2026 (instead of April 3, 2026). The updated release reads: SCOTT+SCOTT ATTORNEYS AT LAW LLP FILES SECURITIES CLASS ACTION AGAINST PICARD MEDICAL INC. (NASDAQ: PMI) Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Picard Medical Inc....

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Hub Group, Inc. (NASDAQ: HUBG)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Hub Group is a transport...
Back to Newsroom